HRP20120496T1 - Derivati pirolopiridin karboksamida njihovo dobivanje i upotreba u terapiji - Google Patents

Derivati pirolopiridin karboksamida njihovo dobivanje i upotreba u terapiji Download PDF

Info

Publication number
HRP20120496T1
HRP20120496T1 HRP20120496AT HRP20120496T HRP20120496T1 HR P20120496 T1 HRP20120496 T1 HR P20120496T1 HR P20120496A T HRP20120496A T HR P20120496AT HR P20120496 T HRP20120496 T HR P20120496T HR P20120496 T1 HRP20120496 T1 HR P20120496T1
Authority
HR
Croatia
Prior art keywords
cycloalkyl
alkylene
alkyl
aryl
heteroaryl
Prior art date
Application number
HRP20120496AT
Other languages
English (en)
Croatian (hr)
Inventor
Laurent@Dubois
Yannick@Evanno
Andr�@Malanda
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HRP20120496T1 publication Critical patent/HRP20120496T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20120496AT 2007-01-19 2008-01-17 Derivati pirolopiridin karboksamida njihovo dobivanje i upotreba u terapiji HRP20120496T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700356A FR2911605B1 (fr) 2007-01-19 2007-01-19 Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
PCT/FR2008/000054 WO2008107543A2 (fr) 2007-01-19 2008-01-17 Derives de pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
HRP20120496T1 true HRP20120496T1 (hr) 2012-07-31

Family

ID=38457983

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120496AT HRP20120496T1 (hr) 2007-01-19 2008-01-17 Derivati pirolopiridin karboksamida njihovo dobivanje i upotreba u terapiji

Country Status (18)

Country Link
US (1) US8044066B2 (de)
EP (1) EP2106401B1 (de)
JP (1) JP5264772B2 (de)
AR (1) AR064936A1 (de)
AT (1) ATE549339T1 (de)
CL (1) CL2008000128A1 (de)
CY (1) CY1112855T1 (de)
DK (1) DK2106401T3 (de)
ES (1) ES2384289T3 (de)
FR (1) FR2911605B1 (de)
HR (1) HRP20120496T1 (de)
PE (1) PE20081701A1 (de)
PL (1) PL2106401T3 (de)
PT (1) PT2106401E (de)
SI (1) SI2106401T1 (de)
TW (1) TW200836726A (de)
UY (1) UY30875A1 (de)
WO (1) WO2008107543A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926556B1 (fr) * 2008-01-22 2010-02-19 Sanofi Aventis Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
FR2926554B1 (fr) 2008-01-22 2010-03-12 Sanofi Aventis Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
TWI501967B (zh) * 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
US20210253772A1 (en) 2020-02-18 2021-08-19 Covestro Llc Polyoxazolidinone compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005427A (es) 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
ATE416168T1 (de) 2002-02-15 2008-12-15 Glaxo Group Ltd Modulatoren des vanilloidrezeptors
EP1636224B1 (de) 2003-05-21 2010-07-14 Prosidion Limited Pyrrolopyridin-2-carbonsäuren als hemmer der glycogenphosphorylase
US7544803B2 (en) * 2004-01-23 2009-06-09 Amgen Inc. Vanilloid receptor ligands and their use in treatments
GB0403819D0 (en) * 2004-02-20 2004-03-24 Merck Sharp & Dohme New compounds
US20090298745A1 (en) 2004-12-02 2009-12-03 Gerard Hugh Thomas Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
CA2598273A1 (en) 2005-02-17 2006-08-24 Merck & Co., Inc. Method of treating atherosclerosis, dyslipidemias and related conditions
FR2888847B1 (fr) * 2005-07-22 2007-08-31 Sanofi Aventis Sa Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2897061B1 (fr) * 2006-02-03 2010-09-03 Sanofi Aventis Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
JP5264772B2 (ja) 2013-08-14
EP2106401B1 (de) 2012-03-14
ES2384289T3 (es) 2012-07-03
ATE549339T1 (de) 2012-03-15
PE20081701A1 (es) 2008-12-31
WO2008107543A3 (fr) 2008-12-24
WO2008107543A2 (fr) 2008-09-12
DK2106401T3 (da) 2012-07-02
CY1112855T1 (el) 2016-02-10
UY30875A1 (es) 2008-09-02
CL2008000128A1 (es) 2008-05-23
FR2911605A1 (fr) 2008-07-25
PT2106401E (pt) 2012-06-18
US8044066B2 (en) 2011-10-25
PL2106401T3 (pl) 2012-08-31
EP2106401A2 (de) 2009-10-07
JP2010516661A (ja) 2010-05-20
AR064936A1 (es) 2009-05-06
FR2911605B1 (fr) 2009-04-17
TW200836726A (en) 2008-09-16
SI2106401T1 (sl) 2012-07-31
US20090298865A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
ES2344087T3 (es) Derivados de n-heteroaril-carboxamidas triciclicas que contienen un resto bencimidazol, su preparacion y su aplicacion en terapeutica.
ES2629414T3 (es) Derivados de tiazol
CA3072362A1 (en) Inhibiting ubiquitin specific peptidase 30
ES2627788T3 (es) Compuestos heteroarilo y procedimientos de uso de los mismos
ES2401129T3 (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
CN107660199A (zh) 哌嗪氨基甲酸酯及其制备和使用方法
WO2019110663A1 (en) 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors
NZ587014A (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
CN101820764A (zh) 治疗用异噁唑化合物
CA2994203A1 (en) Azaspiro compounds as muscarinic agonists
KR20090130347A (ko) 치환된 헤테로사이클릭 유도체 및 조성물 및 항균제로서의 이의 약학적 용도
HRP20100150T1 (hr) N-(arilalkil)-1h-pirolopiridin-2-karboksamidni derivati, njihovo dobivanje i upotreba
ES2745555T3 (es) Derivados de piperazina y el uso de los mismos como medicamento
JP2024038202A (ja) ヒストンデアセチラーゼの阻害剤
US10870630B2 (en) Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
ES2329413T3 (es) 3-amino-2-arilpropil azaindoles y usos de los mismos.
JP2022553284A (ja) Ｔｒｅｋ（ｔｗｉｋ関連ｋ＋チャネル）チャネル機能の阻害剤
CN101300226B (zh) 对组蛋白脱乙酰酶具有抑制活性的烷基氨甲酰基萘氧基辛烯酰基羟基酰胺衍生物及其制备方法
JP3169188B2 (ja) カルバミン酸誘導体及びその製造方法
US8044066B2 (en) Derivatives of pyrrolopyridine-2-carboxamides, preparation thereof and therapeutic application thereof
AU2017326359B2 (en) Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors
KR20190027877A (ko) 트립토판 2,3-디옥시제나제(Tryptophan 2,3-dioxygenase)의 억제제 (Inhibitors of Tryptophan 2,3-dioxygenase)
AU2020267757B2 (en) Inhibiting USP19
CN105189485A (zh) 作为抗疟剂的新型丙烯酰胺衍生物
US20120058999A1 (en) Substituted Tetrahydropyrrolopyrazine Compounds